FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3204341115> ?p ?o ?g. }

• W3204341115 endingPage "2101999" @default.
• W3204341115 startingPage "2101999" @default.
• W3204341115 abstract "Targeting the epidermal growth factor receptor (EGFR) with tyrosine kinase inhibitors (TKIs) is one of the major precision medicine treatment options for lung adenocarcinoma. Due to common development of drug resistance to first- and second-generation TKIs, third-generation inhibitors, including osimertinib and rociletinib, have been developed. A model of EGFR-driven lung cancer and a method to develop tumors of distinct epigenetic states through 3D organotypic cultures are described here. It is discovered that activation of the EGFR T790M/L858R mutation in lung epithelial cells can drive lung cancers with alveolar or bronchiolar features, which can originate from alveolar type 2 (AT2) cells or bronchioalveolar stem cells, but not basal cells or club cells of the trachea. It is also demonstrated that these clones are able to retain their epigenetic differences through passaging orthotopically in mice and crucially that they have distinct drug vulnerabilities. This work serves as a blueprint for exploring how epigenetics can be used to stratify patients for precision medicine decisions." @default.
• W3204341115 created "2021-10-11" @default.
• W3204341115 creator A5003322678 @default.
• W3204341115 creator A5008563017 @default.
• W3204341115 creator A5009997945 @default.
• W3204341115 creator A5015978857 @default.
• W3204341115 creator A5029676790 @default.
• W3204341115 creator A5032307069 @default.
• W3204341115 creator A5036854706 @default.
• W3204341115 creator A5040212698 @default.
• W3204341115 creator A5044468709 @default.
• W3204341115 creator A5067230085 @default.
• W3204341115 creator A5067316461 @default.
• W3204341115 creator A5087590041 @default.
• W3204341115 date "2021-10-07" @default.
• W3204341115 modified "2023-10-10" @default.
• W3204341115 title "Cellular Origins of EGFR‐Driven Lung Cancer Cells Determine Sensitivity to Therapy" @default.
• W3204341115 cites W1651832009 @default.
• W3204341115 cites W1972570571 @default.
• W3204341115 cites W1974213646 @default.
• W3204341115 cites W1990013637 @default.
• W3204341115 cites W1999574084 @default.
• W3204341115 cites W2014445008 @default.
• W3204341115 cites W2015254140 @default.
• W3204341115 cites W2021312892 @default.
• W3204341115 cites W2041535798 @default.
• W3204341115 cites W2071480068 @default.
• W3204341115 cites W2075658406 @default.
• W3204341115 cites W2092023463 @default.
• W3204341115 cites W2105902643 @default.
• W3204341115 cites W2114104545 @default.
• W3204341115 cites W2120876285 @default.
• W3204341115 cites W2124295094 @default.
• W3204341115 cites W2130410032 @default.
• W3204341115 cites W2131271579 @default.
• W3204341115 cites W2140239301 @default.
• W3204341115 cites W2143951787 @default.
• W3204341115 cites W2155379880 @default.
• W3204341115 cites W2161821474 @default.
• W3204341115 cites W2164730783 @default.
• W3204341115 cites W2179438025 @default.
• W3204341115 cites W2230320310 @default.
• W3204341115 cites W2325071936 @default.
• W3204341115 cites W2346025119 @default.
• W3204341115 cites W2394765893 @default.
• W3204341115 cites W2400274474 @default.
• W3204341115 cites W2604498317 @default.
• W3204341115 cites W2747965175 @default.
• W3204341115 cites W2750493351 @default.
• W3204341115 cites W2767661899 @default.
• W3204341115 cites W2781759361 @default.
• W3204341115 cites W2790922923 @default.
• W3204341115 cites W2803252816 @default.
• W3204341115 cites W2887768610 @default.
• W3204341115 cites W2889862256 @default.
• W3204341115 cites W2892249755 @default.
• W3204341115 cites W2912844538 @default.
• W3204341115 cites W2924349320 @default.
• W3204341115 cites W2947490329 @default.
• W3204341115 cites W2971879199 @default.
• W3204341115 cites W2972329402 @default.
• W3204341115 cites W3010996890 @default.
• W3204341115 cites W3014482292 @default.
• W3204341115 cites W3044772769 @default.
• W3204341115 cites W3083501712 @default.
• W3204341115 cites W3083980594 @default.
• W3204341115 cites W3085113888 @default.
• W3204341115 cites W3095217155 @default.
• W3204341115 cites W3101182234 @default.
• W3204341115 cites W3109371411 @default.
• W3204341115 cites W3204341115 @default.
• W3204341115 doi "https://doi.org/10.1002/advs.202101999" @default.
• W3204341115 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/8596110" @default.
• W3204341115 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/34622577" @default.
• W3204341115 hasPublicationYear "2021" @default.
• W3204341115 type Work @default.
• W3204341115 sameAs 3204341115 @default.
• W3204341115 citedByCount "13" @default.
• W3204341115 countsByYear W32043411152021 @default.
• W3204341115 countsByYear W32043411152022 @default.
• W3204341115 countsByYear W32043411152023 @default.
• W3204341115 crossrefType "journal-article" @default.
• W3204341115 hasAuthorship W3204341115A5003322678 @default.
• W3204341115 hasAuthorship W3204341115A5008563017 @default.
• W3204341115 hasAuthorship W3204341115A5009997945 @default.
• W3204341115 hasAuthorship W3204341115A5015978857 @default.
• W3204341115 hasAuthorship W3204341115A5029676790 @default.
• W3204341115 hasAuthorship W3204341115A5032307069 @default.
• W3204341115 hasAuthorship W3204341115A5036854706 @default.
• W3204341115 hasAuthorship W3204341115A5040212698 @default.
• W3204341115 hasAuthorship W3204341115A5044468709 @default.
• W3204341115 hasAuthorship W3204341115A5067230085 @default.
• W3204341115 hasAuthorship W3204341115A5067316461 @default.
• W3204341115 hasAuthorship W3204341115A5087590041 @default.
• W3204341115 hasBestOaLocation W32043411151 @default.
• W3204341115 hasConcept C104317684 @default.
• W3204341115 hasConcept C121608353 @default.
• W3204341115 hasConcept C126322002 @default.

• next